Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS).

Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS). Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS). Abstract Text:

Simon Smith,Karen Sullivan,Wendy Hopkins,James Douglas,

Background and purpose: Insomnia and Obstructive Sleep Apnoea Hypopnea Syndrome (OSAHS) are the two most common sleep disorders, and both have significant associated health costs. Despite this, relatively little is known about the prevalence or impact of insomnia in those with OSAHS, although a recent study suggested there may be substantial comorbidity between these disorders [Chest 120 (2001) 1923-9]. The primary aim of this study was to further explore the prevalence of insomnia in OSAHS. A secondary aim was to assess the effect of factors that may impact on both conditions, including mood and sleep-beliefs. Patients and methods: Consecutive patients referred to an accredited Sleep Investigations Unit [Formula: see text] completed a brief standardized battery of validated questionnaires assessing sleep-related variables and mood. Results: Results showed a high rate of prevalence of clinical insomnia in this OSAHS population, and a strong positive correlation between OSAHS and insomnia symptom severity. Further, OSAHS patients with comorbid insomnia had increased levels of depression, anxiety and stress compared to patients with OSAHS-only, and both patient groups reported similar and significant levels of dysfunctional beliefs about sleep. Findings in relation to habitual sleep, assessed using subjective (diary) and objective criteria (polysomnogram), were mixed but generally showed greater sleep disturbance among those with OSAHS-insomnia compared to those with OSAHS-only. Conclusions: Overall these findings suggest that comorbidity of insomnia in OSAHS patients may lead to increased OSAHS severity and that patients with both conditions may experience more symptoms relating to depression, anxiety and stress. These findings underscore the need for insomnia assessment and management services, even in clinics that primarily service patients with OSAHS.

Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS). Publishing Authors By Initials

S Smith,K Sullivan,W Hopkins,J Douglas,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS). Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Sleep medicine

VOLUME: 5

Page Numbers: 449-56

Journal Abbreviation: Sleep Med.

ISSN: 1389-9457

DAY: 2

MONTH: Sep

YEAR: 2004

Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS). Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100898759

Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS). Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS). Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS).

AFFILIATION: The Prince Charles Hospital, Brisbane, Australia.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Sleep Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome OSAHS Related Publications

• Adenoviral vectors for gene therapy.
• Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients.
• Blastocyst-derived trophoblast stem cells from the rhesus monkey.
• Cell death, remodeling, and repair in chronic obstructive pulmonary disease?
• Consumer acceptable risk: how cigarette companies have responded to accusations that their products are defective.
• Control of ovulation in cycling mares with ovarian steroids and prostaglandin.
• Controlled ligand display on a symmetrical protein-cage architecture through mixed assembly.
• Converging epistemologies: critical issues in Canadian Inuit childbirth and pregnancy.
• Cross-linkage of hydroxyapatite/gelatin nanocomposite using imide-based zero-length cross-linker.
• Culture-negative Bartonella endocarditis in a patient with renal failure: the value of molecular methods in diagnosis.
• Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS).
• Functional status in patients with narcolepsy.
• Fuzzy clustering of CT images for the measurement of hydrocephalus associated with tuberculous meningitis.
• High-density targeting of a viral multifunctional nanoplatform to a pathogenic, biofilm-forming bacterium.
• Left ventricular hypertrophy in athletes: morphologic features and clinical correlates.
• Lipid A fraction of LPS induces a discrete MAPK activation in acute lung injury.
• MUC1 is involved in trophoblast transendothelial migration.
• Measurement of plasma-derived substance P: biological, methodological, and statistical considerations.
• Metabolic flux analysis for optimizing the specific growth rate of recombinant Aspergillus niger.
• Plasma oxytocin concentrations in cyclic mares and sexually aroused stallions.
• Predictors of hepatitis B vaccination in women prisoners in two prisons in England.
• Preliminary findings of an intervention integrating modified directly observed therapy and risk reduction counseling.
• Relationship between the ability of oral streptococci to interact with platelet glycoprotein Ibalpha and with the salivary low-molecular-weight mucin, MG2.
• Sequence variation in alpha-methylacyl-CoA racemase and risk of early-onset and familial prostate cancer.
• Synthetic control over magnetic moment and exchange bias in all-oxide materials encapsulated within a spherical protein cage.
• Target-assembled ExciProbes: Application to DNA Detection at the Level of PCR Product and Plasmid DNA.
• Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles.
• The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects.
• The outcome of twin pregnancies in mares.
• The use of radioreceptor assay for the detection of pregnancy in the mare.